Home>Clinical Trials>Available Clinical Trials

Available Kidney Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
E-mail: askrpci@roswellpark.org

A Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic Renal Cell Carcinoma -
COG ADVL1121) A Phase II study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults with Relapsed/Refract. Rhabdomyosarcoma, Wilms Tumor, Hepatocellular, and Papillary Thyroid Ca...
A Phase I/II Study of the HDAC Inhibitor LBH589 in Combination with the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
A Pilot Clinical Trial of Neoadjuvant Tivozanib in Localized Renal Cell Carcinoma
Phase I/II Study of Dalteparin, A Low Molecular Weight Heparin (LMWH), in Combination with Sunitinub (SU11248), an Oral, Selective Multitareted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients with Metastati...
A Randomized, Open-Label, Phase 3 Study of BMS-936558 vs. Everolimus in Subjects with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors. Hoosier Oncology Group GU09-145